Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 3Prostatic Neoplasms 1Depression 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2068Radiotherapy 1990Cisplatin 1857Carboplatin 1560Gemcitabine 1455Paclitaxel 1322Bevacizumab 1321pembrolizumab 1240Docetaxel 1227Oxaliplatin 1184Capecitabine 1179Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 973Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 641Lenalidomide 619Biopsy 595Specimen Handling 570

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Stress Mindset Measure × Clear all
NCT06811454 2026-01-23

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

Case Comprehensive Cancer Center

Phase NA Not yet recruiting
76 enrolled
BreastGastrointestinalGenitourinary

Breast Neoplasms, Depression, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06705218 2026-01-07

EMBRACE

Stanford University

Phase NA Recruiting
440 enrolled
Tumor-Agnostic

Neoplasms

NCT04020029 2025-12-19

Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer

Stanford University

Phase NA Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡